JohnZaiaMD

PubMed

• 13 citations
  Large-scale manufacturing and characterization of CMV-CD19CAR T cells.
  Xiuli Wang, Ryan Urak, Miriam Walter, Min Guan, Tianxu Han
  Journal for Immunotherapy of Cancer. 2022-01-01
• In the Fog of COVID.
  John A. Zaia
  Clinical Infectious Diseases. 2020-08-28
• 4 citations
  Safety of Isavuconazonium Sulfate in Pediatrics Patients With Hematologic Malignancies and Hematopoietic Cell Transplantation With Invasive Fungal Infections: A Real W...
  J. Ross, Nicole Karras, Bernard Tegtmeier, Chris Yamada, Jason Chen
  Journal of Pediatric Hematology/oncology. 2020-05-01

Journal Articles

• Practical Considerations in Gene Therapy for HIV Cure  
  Stan R, Zaia J, Current HIV/AIDS Reports, 1/1/2014
• In Vivi Evidence Insufficient to Conclude that "KIR/HLA Incompatibility Between Sexual Partners Confers Protection Against HIV-1 Transmission"  
  Behrendt CE, Zaia JA, Blood, 9/12/2013
• Detection and preliminary characterization of CD8 T lymphocytes specific for Wilms' tumor antigen in patients with non-Hodgkin lymphoma Leuk Lymphoma  
  Israyelyan A, La Rosa C, Tsai W, Kaltcheva T, Srivastava T, Aquino L, Li J, Kim Y, Palmer J, Streja L, Senitzer D, Zaia J A, Rosenwald A, Forman S J, Nakamura R, Diamo..., Leuk Lymphoma, 1/1/2013
• Plasma Viremia and Cellular HIV-1 DNA Persist Despite Autologous Hematopoietic Stem Cell Transplantation for HIV-Related Lymphoma  
  Cillo AR, Krishnan A, Mitsuyasu RT, McMahon DK, Li S, Rossi JJ, Zaia JA, Mellors JW, J Acquired Immune Defic Syndromes, 1/1/2013
• Hematopoietic Cell Transplantation with Cord Blood for Cure of HIV Infections  
  Petz, L.D., Redei, I., Bryson, Y., Regan, D., Kurtzberg, J., Shpall, E., Gutman, J., Querol, S., Clark, P., Tonai, R., Santos, S., Bravo, A., Spellman, S., Gragert, L...., Biology of Blood and Marrow Transplantation, 1/1/2013
• Donor killer immunoglobulin-like receptor genes and reactivation of cytomegalovirus after HLA-matched hematopoietic stem-cell transplantation: HLA-C allotype is an ess...  
  Behrendt CE, Nakamura R, Forman SJ, Zaia JA, Frontiers in Immunology, 1/1/2013
• Cytomegalovirus Viral Load and Virus-Specific Immune Reconstitution after Peripheral Blood Stem Cell versus Bone Marrow Transplantation  
  Guerrero, A., Riddell, S.R., Storek, J., Stevens-Ayers, T., Storer, B., Zaia, J.A., Forman, S., Negrin, R.S., Chauncey, T., Bensinger, W., and Boeckh, M, Biology of Blood and Marrow Transplantation, 1/1/2012
• Creating genetic resistance to HIV  
  Burnett JC, Zaia JA, Rossi JJ, Curr Opin Immunol, 1/1/2012
• KIR2DS2 and KIR2DS4 Promoter hypomethylation patterns in patients undergoing hematopoietic cell transplantation (HCT)  
  Gallez-Hawkins GM, Li X, Franck AE, Genzekhadze K, Nakamura R, Forman SJ, Senitzer D, Zaia JA, Hum Immunol, 1/1/2012
• Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and Tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant  
  La Rosa C, Longmate J, Lacey SF, Kaltcheva T, Sharan R, Drake J, Williams B, Denison S, Broyer S, Couture L, Kelsey M, Krieg AM, Diamond DJ, Zaia JA, Journal of Infectious Disease, 1/1/2012
• Expression of activating KIR2DS2 and KIR2DS4 genes following hematopoietic cell transplant (HCT): relevance to cytomegalovirus (CMV) infection  
  Gallez-Hawkins GM, Franck AE, Xiuli L, Thao L, Oki A, Gendzekhadze K, Dagis A, Palmer J, Nakamura R, Forman SJ, Senitzer D, Zaia JA, Biol Blood Marrow Transplant, 1/1/2011
• Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years  
  Hutter G, Zaia JA, Clinical and Experimental Immunology, 1/1/2011
• The Effect of Single and Combined Activating KIR Genotypes on CMV infection and Immunity after Hematopoietic Cell Transplantation  
  Zaia JA, Sun JY, Gallez-Hawkins GM, Thao L, Oki A, Lacey SF, Dagis A, Palmer J, Forman SF, Senitzer D, Biol Blood Marrow Transplant, 1/1/2009
• Increased Programmed Death-1 Molecule Expression in Cytomegalovirus Disease and Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell  
  Gallez-Hawkins GM, Thao L, Palmer J, Dagis A, Li X, Franck AE, Tegtmeier B, Lacey SF, Diamond DJ, Forman, SF, and Zaia JA, Biol Blood Marrow Transplant, 1/1/2009
• Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipient  
  Zhou W, Longmate J, Lacey SF, Palmer JM, Gallez-Hawkins GM, Thao L, Spielberg R, Nakamura Y, Forman SJ, Zaia JA, Diamond DJ, Blood, 1/1/2009
• Mini Review: Should HIV-positive patients with lymphoma be offered stem cell transplants?  
  Krishnan A, Zaia J, Forman SJ, Biol Blood Marrow Transplant, 1/1/2003
• Novel ribozyme, RNA decoy, and siRNA approaches to inhibition of HIV in a gene therapy setting  
  Michienzi A, Castanotto D, Lee N, Li S, Zaia JA, Rossi JJ, Clin and Applied Immunol Reviews, 1/1/2003
• Problems and solutions to successful gene-transfer based therapies for HIV  
  Zaia JA, Clin and Applied Immunol Reviews, 1/1/2002
• Ex vivo selection and expansion of cells based on expression of a mutated inosine monophosphate dehydrogenase 2 after HIV vector transduction: Effect on lymphocytes, m...  
  Yam P, Jensen M, Akkina R, Anderson, J, Villacres MC, Wu J, Zaia JA, Yee J-K, Mol Ther, 1/1/2002
• Prevention of Cytomegalovirus Disease in Hematopoietic Stem Cell Transplantation  
  Zaia John A, Clinical Infectious Diseases, 1/1/2002
• A nucleolar TAR decoy inhibitor of HIV-1 replication  
  Michienzi A, Li S, Zaia JA, Rossi JJ, Proc Natl Acad Sci USA, 1/1/2002
• Mini-review: Prevention and management of CMV-related problems after hematopoietic stem cell transplantation  
  Zaia JA, BMT, 1/1/2002
• Hematologic Aspects of HIV/AIDS  
  Levine AM, Scadden DT, Zaia JA, Krishnan A, Hematology (Am Soc Hematol Educ Program), 1/1/2001
• Infrequent occurrence of natural mutations in the pp65 (495-503) epitope sequence presented by the HLA A*0201 allele among human cytomegalovirus isolates  
  Zaia JA, Gallez-Hawkins G, Li X, Yao ZQ, Lomeli N, Molinder K, La Rosa C, Diamond DJ, J Virol, 1/1/2001
• Status of Cytomegalovirus Prevention and Treatment in 2000  
  Zaia JA, Sissons JG, Riddell S, Diamond DJ, Wills MR, Carmichael AJ, Weekes MP, Gandhi M, La Rosa C, Villacres M, Lacey S, Markel S, Sun J, Hematology (Am Soc Hematol Educ Program), 1/1/2000
• Join now to see all

Books/Book Chapters

• Clinical Virology 
  Chapter: Infections in Organ Transplant Recipients. 
  Page 81 - 96Zaia John AEditors: Richman, Whitley, & Hayden.ASM Press, Washington, DCEdition 3rd,2009
• Thomas' Hematopoietic Cell Transplantation 
  Chapter: Hematopoietic Cell Transplantation for Patient with Human Immunodeficiency Virus Infection. 
  Zaia John A, Krishnan Amrita, Rossi John JEditors: Appelbaum, Forman, Negrin & Blume.Blackwell PublishingEdition 4th,2009
• Clinical Infectious Disease 
  Chapter: Varicella-Zoster Virus. 
  Page 1311 - 1318Zaia John AEditors: Schlossberg D..Cambridge University Press, New York2008
• Institutional Review Board-Management and Function 
  Chapter: Expedited Institutional Review Board Review. 
  Page 97 - 100Oki GSF, Zaia John AEditors: Bankert EA and Amdur RJ.Jones and Bartlett Publishers, Sudbury2006
• APIC Text of Infection Control and Epidemiology 
  Chapter: Herpesviruses. 
  Page 1 - 20Zaia John AnthonyAssociation for Professionals in Infection Control and Epidemiology, Inc.Edition 2nd,2005
• Thomas' Hematopoietic Cell Transplantation 
  Chapter: Cytomegalovirus Infection. 
  Page 701 - 726Zaia John AEditors: Blume, Forman, Appelbaum.Blackwell PublishingEdition 3rd,2004
• Thomas' Hematopoietic Cell Transplantation 
  Chapter: AIDS and Hematopoietic Transplantation: HIV Infection, AIDS Lymphoma and Gene Therapy. 
  Page 1369 - 1384Zaia John A, Cairns Scott & Rossi John JEditors: Blume, Forman, Appelbaum.Blackwell PublishingEdition 3rd,2004
• Lentiviral Vector Systems for Gene Transfer 
  Chapter: Prospects for Gene Therapy using HIV-Based Vectors. 
  Page 159 - 174Yee JK, Zaia JAEditors: Gary L. BUniversity of Southern Californiahacher, Jr.Kluwer Academic/ Plenum Publishers2003
• APIC Text of Infection Control and Epidemiology 
  Chapter: Herpes Viruses. 
  Zaia JohnAssociation for Professionals in Infection Control and Epidemiology, Inc.2003
• Infectious Complications in Transplant Recipients 
  Chapter: Advances in CMV Diagnostic Testing and Their Implications for the Management of CMV Infection in Transplant Recipients. 
  Page 75 - 92Zaia JA and Molinder KMKluwer Academic Publishers2001
• Current Therapy of Infectious Disease 
  Chapter: Varicella-Zoster Virus. 
  Page 498 - 505Zaia John AEditors: Schlossberg D..Mosby1996
• Advances in Molecular Biology and Targeted Treatment for AIDS 
  Chapter: Antiviral Evaluation of HIV-1 Specific Ribozyme Expressed in CD4+ HeLa Cells. 
  Page 335 - 344Zaia, John A, E Cantin, PS Chang, N Server and J RossiEditors: Kumar.Plenum Press1991
• Join now to see all

Abstracts/Posters

• Large-Scale Manufacturing of CMV-CD19CAR T Cells and Characterization of Their Biologic and Immunologic Properties
  John Zaia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Updated Analysis: Novel Machine-Learning-Based Sepsis Prediction Model for Patients Undergoing Hematopoietic Stem Cell Transplantation (Early Sepsis Prediction/Identif...
  John Zaia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Enhanced antitumor efficacy of adoptively transferred CD19-redirected CMV specific central memory T cells by CMV vaccine.
  Xiuli Wang, Winnie Wong, Wen-Chung Chang, Don Diamond, Michael C. Jensen, Christine E. Brown, John A Zaia, Stephen J. Forman, ASH, Atlanta, GA, 12/8/2012
• Costimulatory molecule profiles and NK cell recovery after autologous hematopoietic cell transplantation (HCT) in multiple myeloma (MM) patients.
  Myo Htut, Ghislaine Gallez-Hawkins, Joycelynne Palmer, Xueli Liu, Ricardo Tomas Spielberger, Pablo Miguel Parker, Len Farol, Anne Franck, Xiuli Li, Laetitia Jeannet, E..., 2012 ASCO Meeting, Chicago, IL, 6/1/2012
• Protein Kinase c Activators enhance Zinc finger nuclease-Driven Genome editing in hematopoietic Stem/progenitor cells.
  Lijing Li, Ludmila Krymskaya, Jianbin Wang, Kenneth Kim, Lanfeng Cao, Anitha Rao, Nancy Gonzalez, Cyh-Anh Tran, Monica Coronado, Agnes Gardner, Amira Ahmed, Paula Cann..., 15th Annual ASGCT, Philadelphia, PA, 5/16/2012
• Plasma Viremia and Cellular HIV-1 DNA Persist Despite Autologous Hematopoietic Stem Cell Transplantation for AIDS-Related Lymphoma.
  Anthony Cillo, Amrita Krishnan, Ronald Mitsuyasu, Deborah McMahon, Shirley Li, John Rossi, John Zaia, John Mellors, 19th CROI, Seattle, WA, 3/5/2012
• Plasma Viremia and Cellular HIV-1 DNA Persist Despite Autologous Hematopoietic Stem Cell Transplantation for AIDS-related Lymphoma.
  Anthony Cillo, A Krishnan, R Mitsuyasu, D McMahon, S Li, J Rossi, J Zaia, and J Mellors, 19th Conference on Retroviral and Opportunistic Infections, Seattle, WA, 3/5/2012
• Cord Blood Transplantation for Long Term Management or Possible Cure of HIV Infection.
  Lawrence Petz M.D., Richard Tonai, Istvan Redei M.D., Shirley Li M.D., Haitang Li, Yvonne Bryson M.D., Donna Regan, Stephen Spellman, Loren Gragert, Michael Boo, Jonat..., BMT Tandem Meetings, San Diego, CA, 2/1/2012
• Safety and Feasibility of Lentivirus-Transduced Hematopoietic Progenitor Cell Therapy (HCT) for AIDS Lymphoma: Year 1 Follow-Up Results.
  Zaia JA, DiGiusto D, Krishnan A, Couture L, Hsu D, Li M, Kalos M, Lacey S, Yee J-K, Palmer J, Li L, Rao A, Mi S, Yam P, Li S, Li H, Stinson S, Alvarnas J, Forman SJ, a..., ASGT 12th Annual Meeting, San Diego, CA, 5/27/2009
• Increased PD-1 expression in patients with CMV disease and acute GVHD after allogeneic HCT: clues to pathogenesis.
  J.A. Zaia, G.M. Gallez-Hawkins, L. Thao, J. Palmer, A. Dagis, X. Li, A.E. Franck, B. Tegtmeier, S.F. Lacey, D.J. Diamond, S.J. Forman, 12th International CMV/BetaHerpesvirus Workshop, Boston, MA, 5/10/2009
• Delayed Cytomegalovirus (cmv) Infection Following Hematopoietic Cell Transplantation (HCT): City of Hope (COH) Experience.
  Alexandra Schaible, Allison Mays, Can-Lan Sun, Liton Francisco, Lennie Wong, Jon Sharp, Lester Laddaran, Stephen Forman, John Zaia, Sanjeet Dadwal, and Smita Bhatia, Blood (ASH Annual Meeting Abstracts), 11/1/2008
• Impact of Donor CMV Serostatus on Immunologic Reconstitution and CMV Reactivation of CMV0Seropositive Recipients Post-HCT.
  Zhou W, Lalcey SF, Longmate J, Palmer J, Gallez-Hawkins G, Thao L, Spielberger R, Forman SJ, Zaia JA and Diamond DJ, 1st Annual COH Poster Session Collaboration: A Catalyst for Progress, Duarte, CA, 6/1/2008
• The Effect of KIR Genes Versus Haplotypes on CMV Reactivation after Hematopoietic Cell Transplantation (HCT).
  Sun J, Gallez-Hawkins G, Thao L, Oki Arisa, Palmer J, Dagis A, Forman SJ, Zaia JA and Senitzer D, 1st Annual COH Poster Session COLLABORATION: A Catalyst for Progress, Duarte, CA, 6/1/2008
• A Fusion Protein of Hcmv le1 Exon4 and le2 Exon 5 Stimulates Potent Cellular Immunity in an MVA Vaccine Vector.
  Wang Z, Zhou W, Strvastava T, La Rosa C, Mandarino A, Forma SJ, Zaia JA, Britt WJ and Diamond DJ, 1st Annual COH Poster Session COLLABORATION: A Catalyst for Progress, Duarte, CA, 6/1/2008
• Characterization of lentivirus vector-based shRNA on chemotherapeutic inhibition of HIV: demonstration of antiviral synergy and identification of shRNA-resistant virus.
  Li S, Meinking K, Li H, Zaia JA and Rossi J, ASGT 11th Annual Meeting, Boston, MA, 5/28/2008
• Effect of antiviral therapy on lentiviral transduction.
  Priscilla Yam, Paola Marcovecchio, Shirley Li, Jiing-Kuan Yee, John A. Zaia, ASGT 11th Annual Meeting, Boston, MA, 5/28/2008
• Presence of Activating KIR Genotypes Influences Cytomegalovirus (CMV) Reactivation as Detected by Q-PCR in HCT Recipients.
  J. Sun, G.M. Gallez-Hawkins, L. Thao, X. Li, A.E. Franck, A. Dagis, D. Senitzer, S.J. Forman, J.A. Zaia, Biology of Blood and Marrow Transplantation, 2/1/2008
• Presence of Activating KIR Genotypes Influences Cytomegalovirus (CMV) Reactivation as Detected by Q-PRC in HCT Recipients.
  Sun J, Gallez-Hawkins GM, Thao L, Li S, Franck AE, Dagis A, Senitzer D, Forman SJ, Zaia JA, BMT Tandem Meeting, 1/1/2008
• PD-1 Expression is Linked to CMV Disease and Prolonged CMV Infection After HCT.
  Gallez-Hawkins GM, Thao L, Palmer J, Li X, Franck AE, Lacey SF, Diamond DJ, Forman SJ, Zaia JA, BMT Tandem Meeting, 1/1/2008
• HIV Status Does Not Affect eh Outcome of Autologous Stem Cell Transplantation (ASCT) for B Cell Non Hodgkin Lymphoma (NHL).
  Krishnan A, Zaia J, Alvarnas J, Kogut N, Spielberger R, Wardlow M, Tsai N, Paris T, Forman SJ, ASH 50th Annual Meeting, San Francisco, CA, 1/1/2008
• First in Human Engraftment of Anti-HIV Lentiviral Vector Gene Modified CD34+ Peripheral Blood Progenitro Cells in the Treatment of AIDS Related Lymphoma (ARI).
  Krishnan A, Zaia JA, Rossi J, DiGiusto D, Kalos M, Couture L, Alvarnas J, Li M, Li H,Yee, J-K, Yam P, Li S, Mi S, Li L, Hsu D, Wardlow M, Duarte L, Rao A, Forman SJ, ASH 50th Annual Meeting, San Francisco, CA, 1/1/2008
• In vitro evaluation of anti-HIV activities in combination of a lentivirus vector-based shRNA with chemotherapeutics.
  Li S, Meinking K, Li H, Zaia JA and Rossi J, COH RSO The 28th Annual Advances, Lake Arrowhead, CA, 1/1/2008
• Characterization of shRNA-resistant HIV-mutants.
  Li S, Meinking K, Li H, Zaia JA and Rossi J, COH RSO The 28th Annual Advances, Lake Arrowhead, CA, 1/1/2008
• A High Throughput Drug Screening Assay for the Anti HIV-1 Replication Cycle.
  Li S, Meinking K, Li H, Zaia JA, COH RSO The 28th Annual Advances, Lake Arrowhead, CA, 1/1/2008
• Potential treatment of HIV-1 infection using siRNA-miRNA hybrid to inhibit HIV-1 replication.
  Yam P, Lo H-L, Chang T, Marcovecchio P, Zaia J, and Yee J-K, AABB Annual Meeting, Anaheim, CA, 10/1/2007
• Join now to see all

Other

• Isolation and characterization of a 64,000 dalton polypeptide of human cytomegalovirus (CMV) using high performance liquid chromatography (HPLC). 
  Zaia JA, Clark B, Eberle R and Ting Y-P
  Cold Springs Harbor, NY - 1/1/1982
• Immunoglobulin in the prevention and treatment of viral disease. Workshop on immunological and pathological aspects of immunoglobulin prophylaxis and therapy. 
  Levin MJ, Zaia JA, Preblud SR and Arbeit RA
  Interlaken, Switzerland - 8/24/1981
• Successful immunoprophylaxis of cytomegalovirus (CMV) infection after marrow transplant with CMV immune globin (CMVig) 
  Meyers JD, Leszczynski J, Zaia JA, Levin MJ, Snydman DR, Wright GG and Thomas ED
  1/1/1981